Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
Brain : a Journal of Neurology
|
December 18, 2015
Migraine induced by hypoxia: an MRI spectroscopy and angiography study
Nanna Arngrim, Henrik Winther Schytz, Josefine Britze, et al.
The Journal of Headache and Pain
|
April 10, 2023
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline
Christian Lampl, Jan Versijpt, Faisal Mohammad Amin, et al.
American Journal of Infection Control
|
January 8, 2025
The impact of implementing a strategy on the rate reduction of catheter-associated urinary tract infections (CAUTI) in national health care facilities in Saudi Arabia
Fayez Aldalbehi, Faisal Mohammad Alsheddi, Mohammad Ali Alqahtani, et al.
The Journal of Headache and Pain
|
October 9, 2023
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate
Bianca Raffaelli, David García-Azorín, Deirdre M Boucherie, et al.
The Journal of Headache and Pain
|
October 17, 2022
CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury
Håkan Ashina, Afrim Iljazi, Haidar M Al-Khazali, et al.
The Journal of Headache and Pain
|
June 5, 2020
Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study
Håkan Ashina, Afrim Iljazi, Haidar Muhsen Al-Khazali, et al.
The Journal of Headache and Pain
|
June 11, 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache
|
November 21, 2023
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 1, 2025
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, et al.
The Journal of Headache and Pain
|
June 27, 2023
Future targets for migraine treatment beyond CGRP
Linda Al-Hassany, Deirdre M Boucherie, Hannah Creeney, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
Brain : a Journal of Neurology
|
December 18, 2015
Migraine induced by hypoxia: an MRI spectroscopy and angiography study
Nanna Arngrim, Henrik Winther Schytz, Josefine Britze, et al.
The Journal of Headache and Pain
|
April 10, 2023
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline
Christian Lampl, Jan Versijpt, Faisal Mohammad Amin, et al.
American Journal of Infection Control
|
January 8, 2025
The impact of implementing a strategy on the rate reduction of catheter-associated urinary tract infections (CAUTI) in national health care facilities in Saudi Arabia
Fayez Aldalbehi, Faisal Mohammad Alsheddi, Mohammad Ali Alqahtani, et al.
The Journal of Headache and Pain
|
October 9, 2023
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate
Bianca Raffaelli, David García-Azorín, Deirdre M Boucherie, et al.
The Journal of Headache and Pain
|
October 17, 2022
CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury
Håkan Ashina, Afrim Iljazi, Haidar M Al-Khazali, et al.
The Journal of Headache and Pain
|
June 5, 2020
Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study
Håkan Ashina, Afrim Iljazi, Haidar Muhsen Al-Khazali, et al.
The Journal of Headache and Pain
|
June 11, 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update
Simona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
Cephalalgia : an International Journal of Headache
|
November 21, 2023
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 1, 2025
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, et al.
The Journal of Headache and Pain
|
June 27, 2023
Future targets for migraine treatment beyond CGRP
Linda Al-Hassany, Deirdre M Boucherie, Hannah Creeney, et al.
Page
of 15